Waldencast plc Announces First Quarter Fiscal 2024 Earnings Release Date, Conference Call and Webcast
NEW YORK, May 13, 2024 (GLOBE NEWSWIRE) — Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, […]
Okeanis Eco Tankers Corp. – Invitation to Q1 2024 Results Conference Call and Webcast
ATHENS, Greece, May 13, 2024 (GLOBE NEWSWIRE) — Okeanis Eco Tankers Corp. (the “Company” or “OET”) (NYSE:ECO / OSE:OET), will […]
O-I Glass Completes Full Allocation for Second Round of Green Bond Offerings
O-I completes full allocation of $690 Million due 2031, issued by Owens-Brockway Glass Container, Inc. O-I completes full allocation of […]
New Gold Increases Exposure in New Afton Copper/Gold Mine to 80% and Launches US$150 Million Bought Deal Financing
(All dollar figures are in US dollars unless otherwise indicated) TORONTO, May 13, 2024 (GLOBE NEWSWIRE) — New Gold Inc. […]
Highwoods Publishes 2023 Corporate Resiliency Report
RALEIGH, N.C., May 13, 2024 (GLOBE NEWSWIRE) — Highwoods Properties, Inc. (NYSE: HIW) has published its 2023 Corporate Resiliency Report, […]
iBio Reports Fiscal Third Quarter 2024 Financial Results and Provides Corporate Update
Strengthened cash position with investment by healthcare specialist investors Expanding into cardio-metabolic space through AstralBio collaboration BRYAN, Texas and SAN […]
Stereotaxis Reports 2024 First Quarter Financial Results
ST. LOUIS, May 13, 2024 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for […]
Stereotaxis Announces Definitive Agreement to Acquire Access Point Technologies
ST. LOUIS, May 13, 2024 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for […]
Fractyl Health Reports First Quarter 2024 Financial Results and Provides Business Updates
Initiation of Remain-1 pivotal study for weight maintenance in patients with obesity after discontinuation of GLP-1 based drugs expected in […]
Acumen Pharmaceuticals to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference
CHARLOTTESVILLE, Va., May 13, 2024 (GLOBE NEWSWIRE) — Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel […]
